MANGALAM

MANGALAM DRUGS AND ORGANICS

Small Cap BSE: 532637 NSE: MANGALAM
₹142.00
-1.6 (-1.11%)
As on 30 September, 2022 | 03:04

Mangalam Drugs And Organics Share Price

Mangalam Drugs And Organics Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in MANGALAM DRUGS AND ORGANICS

Start SIP

Mangalam Drugs And Organics Share Returns

  • Over 1 Month -1.3%
  • Over 3 Month 1.52%
  • Over 6 Month 40.13%
  • Over 1 Year -5.07%

Mangalam Drugs And Organics Key Statistics

P/E Ratio 12.3
PEG Ratio -0.5
Market Cap Cr 225
Price to Book Ratio 1.5
EPS 12.4
Dividend 0
Relative Strength Index 44.62
Money Flow Index 69.61
MACD Signal 1.41
Average True Range 7.7

Mangalam Drugs And Organics Investment Rating

  • Master Rating:
  • Mangalam Drugs & Orgs. has an operating revenue of Rs. 438.49 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 6% is okay, ROE of 13% is good. The company has a reasonable debt to equity of 17%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 9% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -11% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Mangalam Drugs and Organics Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 1091209411410591
Operating Expenses Qtr Cr 99111881099481
Operating Profit Qtr Cr 101065109
Depreciation Qtr Cr 333323
Interest Qtr Cr 433332
Tax Qtr Cr 1-25415
Net Profit Qtr Cr 374542

Mangalam Drugs And Organics Technicals

EMA & SMA

Current Price
144.05
0.45 (0.31%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 148.81
  • 50 Day
  • 146.56
  • 100 Day
  • 141.85
  • 200 Day
  • 131.61
  • 20 Day
  • 150.23
  • 50 Day
  • 146.75
  • 100 Day
  • 140.93
  • 200 Day
  • 131.58

Mangalam Drugs And Organics Resistance and Support

PIVOT
₹144.47
Resistance
First Resistance 146.34
Second Resistance 149.07
Third Resistance 150.94
RSI 44.62
MFI 69.61
MACD Single Line 1.41
MACD 0.05
Support
First Resistance 141.74
Second Resistance 139.87
Third Resistance 137.14

Mangalam Drugs And Organics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 24,639 1,486,471 60.33
Week 31,762 2,127,723 66.99
1 Month 92,081 5,040,496 54.74
6 Month 94,842 4,437,670 46.79

Mangalam Drugs And Organics Result Highlights

Mangalam Drugs and Organics Synopsis

NSE-Medical-Generic Drugs

Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 451.07 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2022. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.
Market Cap 228
Sales 438
Shares in Float 0.79
No of funds 4
Yield 0.68
Book Value 1.51
U/D Vol ratio 1.7
LTDebt / Equity 17
Alpha 0.03
Beta 1.03

Mangalam Drugs and Organics

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 50.42%50.53%50.53%
Foreign Portfolio Investors 0.1%0.1%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 44.18%43.85%44.39%
Others 5.29%5.51%5.07%

Mangalam Drugs and Organics Management

Name Designation
Mr. Govardhan M Dhoot Chairman & Managing Director
Mr. Brijmohan M Dhoot Whole Time Director
Mr. Rakesh K Milwani Non Exe.Non Ind.Director
Mr. Rukmesh P Dhandhania Independent Director
Mrs. Nidhi S Mundada Independent Director
Mr. Praveen Saxena Independent Director

Mangalam Drugs And Organics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Mangalam Drugs And Organics Corporate Action

Date Purpose Remarks
2022-08-05 Quarterly Results
2022-05-26 Audited & Quarterly Results
2022-02-04 Quarterly Results
2021-11-12 Quarterly Results
2021-08-12 Quarterly Results

Mangalam Drugs and Organics FAQs

What is Share Price of Mangalam Drugs and Organics ?

Mangalam Drugs and Organics share price is ₹142 As on 30 September, 2022 | 02:50

What is the Market Cap of Mangalam Drugs and Organics ?

The Market Cap of Mangalam Drugs and Organics is ₹224.8 Cr As on 30 September, 2022 | 02:50

What is the P/E ratio of Mangalam Drugs and Organics ?

The P/E ratio of Mangalam Drugs and Organics is 12.3 As on 30 September, 2022 | 02:50

What is the PB ratio of Mangalam Drugs and Organics ?

The PB ratio of Mangalam Drugs and Organics is 1.5 As on 30 September, 2022 | 02:50

Q1FY23